Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis

Human Molecular Genetics

Volumn 23, Issue 14, 2014, Pages 3883-3890

  Stickel, Felix ^a   Buch, Stephan ^b   Zoller, Heinz ^c   Hultcrantz, Rolf ^d   Gallati, Sabina ^a   Österreicher, Christoph ^e   Finkenstedt, Armin ^c   Stadlmayr, Andreas ^e   Aigner, Elmar ^e   Sahinbegovic, Enijad ^f   Sarrazin, Christoph ^g   Schafmayer, Clemens ^h   Braun, Felix ^h   Erhart, Wiebke ^h   Nothnagel, Michael ^h   Lerch, Markus M ⁱ   Mayerle, Julia ⁱ   Völzke, Henry ⁱ   Schaller, André ^a   Kratzer, Wolfgang ^j   Boehm, Bernhard O ^j   Sipos, Bence ^k   D'Amato, Mauro ^l   Torkvist, Leif ^l   Stal, Per ^d   Arlt, Alexander ^h   Franke, Andre ^h   Becker, Thomas ^h   Krawczak, Michael ^h   Zwerina, Jochen ^m   Berg, Thomas ⁿ   Hinrichsen, Holger ^o   Krones, Elisabeth ^p   Dejaco, Christian ^p   Strasser, Michael ^q   Datz, Christian ^e   Hampe, Jochen ^b   more..

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^h UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

ⁱ UNIVERSITY OF GREIFSWALD   (Germany)

^j UNIVERSITY HOSPITAL ULM   (Germany)

^k UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^l KAROLINSKA INSTITUTE   (Sweden)

^m HANUSCH HOSPITAL   (Austria)

ⁿ UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^o UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^p MEDICAL UNIVERSITY OF GRAZ   (Austria)

^q PARACELSUS MEDICAL UNIVERSITY   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 7; PROTEIN; UNCLASSIFIED DRUG; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN; PCSK7 PROTEIN, HUMAN; SUBTILISIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; IRON METABOLISM; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PENETRANCE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; GENETICS; HUMAN GENOME; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; FEMALE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SUBTILISINS;

EID: 84902978429     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu076     Document Type: Article

References (45)

1. Soranzo, N., Spector, T.D., Mangino, M., Kühnel, B., Rendon, A., Teumer, A., Willenborg, C., Wright, B., Chen, L., Li, M. et al. (2009) Agenome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat. Genet., 41, 1182-1190.
2. Lin, J.P., Schwaiger, J.P., Cupples, L.A., O'Donnell, C.J., Zheng, G., Schoenborn, V., Hunt, S.C., Joo, J. and Kronenberg, F. (2009) Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels - the Framingham Heart Study. Atherosclerosis, 206, 228-233.
3. Sanna, S., Busonero, F., Maschio, A., McArdle, P.F., Usala, G., Dei, M., Lai, S., Mulas, A., Piras, M.G., Perseu, L. et al.. (2009) Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum. Mol. Genet., 18, 2711-2718.
4. Pietrangelo, A. (2010) Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology, 139, 393-408.
5. Beaton, M.D. and Adams, P.C. (2006) Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis. Can. J. Gastroenterol., 20, 257-260.
6. Niederau, C., Fischer, R., Purschel, A., Stremmel, W., Haussinger, D. and Strohmeyer, G. (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology, 110, 1107-1119.
7. Milman, N., Pedersen, P., a Steig, T., Byg, K.E., Graudal, N. and Fenger, K. (2001) Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann. Hematol., 80, 737-744.
8. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., Dormishian, F., Domingo, R. Jr., Ellis, M.C., Fullan, A. et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet., 13, 399-408.
9. Jazwinska, E.C., Cullen, L.M., Busfield, F., Pyper, W.R.,Webb,S.I., Powell, L.W., Morris, C.P. and Walsh, T.P. (1996) Haemochromatosis and HLA-H. Nat Genet, 14, 249-251.
10. Jouanolle, A.M., Gandon, G., Jezequel, P., Blayau, M., Campion, M.L., Yaouanq, J., Mosser, J., Fergelot, P., Chauvel, B., Bouric, P. et al. (1996) Haemochromatosis and HLA-H. Nat. Genet., 14, 251-252.
11. European Association for the Study of Liver Diseases. (2010) EASL clinical practice guidelines for HFE hemochromatosis. J. Hepatol., 53, 3-22.
12. Gleeson, F., Ryan, E., Barrett, S. and Crowe, J. (2004) Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Eur. J. Gastroenterol. Hepatol., 16, 859-863.
13. Powell, L.W., Dixon, J.L., Ramm, G.A., Purdie, D.M., Lincoln, D.J., Anderson, G.J., Subramaniam, V.N., Hewett, D.G., Searle, J.W., Fletcher, L.M. et al. (2006) Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch. Intern. Med., 166, 294-301.
14. Beutler, E., Felitti, V.J., Koziol, J.A., Ho, N.J. and Gelbart, T. (2002) Penetrance of 845G--. A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet, 359, 211-218.
15. Allen, K.J., Gurrin, L.C., Constantine, C.C., Osborne, N.J., Delatycki, M.B., Nicoll, A.J., McLaren, C.E., Bahlo, M., Nisselle, A.E., Vulpe, C.D. et al. (2008) Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med., 358, 221-230.
16. Bulaj, Z.J., Ajioka, R.S., Phillips, J.D., LaSalle, B.A., Jorde, L.B., Griffen, L.M., Edwards, C.Q. and Kushner, J.P. (2000) Disease-related conditions in relatives of patients with hemochromatosis. N. Engl. J. Med., 343, 1529-1535.
17. Benyamin, B., McRae, A.F., Zhu, G., Gordon, S., Henders, A.K., Palotie, A., Peltonen, L., Martin, N.G., Montgomery, G.W., Whitfield, J.B. et al. (2009) Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am. J. Hum. Genet., 84, 60-65.
18. Chambers, J.C., Zhang, W., Li, Y., Sehmi, J., Wass, M.N., Zabaneh, D., Hoggart, C., Bayele, H., McCarthy, M.I., Peltonen, L. et al. (2009) Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat. Genet., 41, 1170-1172.
19. Benyamin, B., Ferreira, M.A., Willemsen, G., Gordon, S., Middelberg, R.P., McEvoy, B.P., Hottenga, J.J., Henders, A.K., Campbell, M.J., Wallace, L. et al. (2009) Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat. Genet., 41, 1173-1175.
20. Oexle, K., Ried, J.S., Hicks, A.A., Tanaka, T., Hayward, C., Bruegel, M., Gögele, M., Lichtner, P., Müller-Myhsok, B., Döring, A. et al. (2011) Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels. Hum. Mol. Genet., 20, 1042-1047.
21. Camaschella, C., Roetto, A., Cali, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A. and Gasparini, P. (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet., 25, 14-15.
22. McLaren, C.E., Garner, C.P., Constantine, C.C., McLachlan, S., Vulpe, C.D., Snively, B.M., Gordeuk, V.R., Nickerson, D.A., Cook, J.D., Leiendecker-Foster, C. et al. (2011) Genome-wide association study identifies genetic loci associated with iron deficiency. PLoS One, 6, e17390.
23. Sookoian, S. and Pirola, C.J. (2011) Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology, 53, 1883-1894.
24. Aleman, S., Endalib, S., Stal, P., Lööf, L., Lindgren, S., Sandberg-Gertzén, H., Almer, S., Olsson, S., Danielsson, A., Wallerstedt, S. et al. (2011) Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population. Scand. J. Gastroenterol., 46, 1118-1126.
25. Baumeister, S.E., Völzke, H., Marschall, P., John, U., Schmidt, C.O., Flessa, S. and Alte, D. (2008) Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology, 134, 85-94.
26. Volzke, H., Alte, D., Schmidt, C.O., Radke, D., Lorbeer, R., Friedrich, N., Aumann, N., Lau, K., Piontek, M., Born, G. et al. (2011) Cohort profile: the study of health in pomerania. Int. J. Epidemiol., 40, 294-307.
27. Stickel, F., Buch, S., Lau, K., Meyer zu Schwabedissen, H., Berg, T., Ridinger, M., Rietschel, M., Schafmayer, C., Braun, F., Hinrichsen, H. et al. (2011) Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology, 53, 86-95.
28. ENCODE Project Consortium Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C. and Snyder, M. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
29. Adams, P.C., Reboussin, D.M., Barton, J.C., McLaren, C.E., Eckfeldt, J.H., McLaren, G.D., Dawkins, F.W., Acton, R.T., Harris, E.L., Gordeuk, V.R. et al. (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med., 352, 1769-1778.
30. Seidah, N.G. and Prat, A. (2012) The biology and therapeutic targeting of the proprotein convertases. Nat. Rev. Drug Discov., 11, 367-383.
31. Rousselet, E., Benjannet, S., Hamelin, J., Canuel, M. and Seidah, N.G. (2011) The proprotein convertase PC7: unique zymogen activation and trafficking pathways. J. Biol. Chem., 286, 2728-2738.
32. Lin, L., Nemeth, E., Goodnough, J.B., Thapa, D.R., Gabayan, V. and Ganz, T. (2008) Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol. Dis., 40, 122-131.
33. Silvestri, L., Pagani, A. and Camaschella, C. (2008) Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood, 111, 924-931.
34. Guillemot, J., Canuel, M., Essalmani, R., Prat, A. and Seidah, N.G. (2013) Implication of the proprotein convertases in iron homeostasis: proprotein convertase 7 sheds human transferrin receptor 1 and furin activates hepcidin. Hepatology, 57, 2514-2524.
35. Schwienbacher, C., Serafin, A., Zanon, A., Pramstaller, P., Pichler, I. and Hicks, A.A. (2013) Involvement of proprotein convertase PCSK7 in the regulation of systemic iron homeostasis. Hepatology, doi: 10.1002/hep.26392.
36. Turpeinen, H., Oksanen, A., Kivinen, V., Kukkurainen, S., Uusimäki, A., Rämet, M., Parikka, M., Hytönen, V.P., Nykter, M. and Pesu, M. (2013) Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor b1a (TGFb1a). J. Biol. Chem., 288, 36610-36623.
37. Bridle, K.R., Crawford, D.H.G. and Ramm, G.A. (2003) Identification and characterization of the hepatic stellate cell transferrin receptor. Am. J. Pathol., 162, 1661-1667.
38. Valenti, L., Fracanzani, A.L., Rametta, R., Fraquelli, M., Soverini, G., Pelusi, S., Dongiovanni, P., Conte, D. and Fargion, S. (2012) Effect of the A736 VTMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis. J. Hepatol., 57, 1319-1325.
39. Adams, P.C. (2005) Screening for haemochromatosis--producing or preventing illness? Lancet, 366, 269-271.
40. Stickel, F., Osterreicher, C.H., Datz, C., Ferenci, P., Wölfel, M., Norgauer, W., Kraus, M.R., Wrba, F., Hellerbrand, C. and Schuppan, D. (2005) Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. Arch. Intern. Med., 165, 1835-1840.
41. Osterreicher, C.H., Datz, C., Stickel, F., Hellerbrand, C., Penz, M., Hofer, H., Wrba, F., Penner, E., Schuppan, D. and Ferenci, P. (2005) Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis. J. Hepatol., 42, 914-919.
42. Ishak, K.G., Zimmerman, H.J. and Ray, M.B. (1991) Alcoholic liver disease:pathologic, pathogenetic and clinical aspects. Alcohol Clin. Exp. Res., 15, 45-66.
43. Hampe, J., Wollstein, A., Lu, T., Frevel, H.J., Will, M., Manaster, C. and Schreiber, S. (2001) An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics, 17, 654-655.
44. Franke, A., Wollstein, A., Teuber, M., Wittig, M., Lu, T., Hoffmann, K., Nürnberg, P., Krawczak, M., Schreiber, S. and Hampe, J. (2006) GENOMIZER: an integrated analysis system for genome-wide association data. Hum. Mutat., 27, 583-588.
45. Dupont, W.D. and Plummer, W.D. (1998) Power and sample size calculations for studies involving linear regression. Control. Clin. Trials, 19, 589-601.